Saida Rahmani

Dr. Saida Rahmani


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

16 January 2024 in Cells
Verified
Journal Article
Open access
PDF file
MNMehdi Najar
Mehdi Najar
SRSaida Rahmani
Saida Rahmani
WFWissam Faour
Wissam Faour
Sami G AlsabriSami G Alsabri
Sami G Alsabri
CLCatherine Lombard
Catherine Lombard
Hassan FahmiHassan Fahmi
Hassan Fahmi
As a form of immunomodulatory therapeutics, mesenchymal stromal/stem cells (MSCs) from umbilical cord (UC) tissue were assessed for their dynamic interplay with the Th-17 immune response pathway. UC-MSCs were able to modulate lymphocyte response by promoting a Th-17-like profile. Such modulation depended on the cell ratio of the cocultures as well as the presence of an inflammatory setting underlying their plasticity. UC-MSCs significantly increased the expression of IL-17A and RORγt but differentially modulated T cell expression of IL-23R. In parallel, the secretion profile of the fifteen factors (IL1β, IL-4, IL-6, IL-10, IL-17A, IL-17F, IL-22, IL-21, IL-23, IL-25, IL-31, IL-33, INF-γ, sCD40, and TNF-α) involved in the Th-17 immune response pathway was substantially altered during these cocultures. The modulation of these factors demonstrates the capacity of UC-MSCs to sense and actively respond to tissue challenges. Protein network and functional enrichment analysis indicated that several biological processes, molecular functions, and cellular components linked to distinct Th-17 signaling interactions are involved in several trophic, inflammatory, and immune network responses. These immunological changes and interactions with the Th-17 pathway are likely critical to tissue healing and may help to identify molecular targets that will improve therapeutic strategies involving UC-MSCs.

15 July 2024 in Biomolecules
Verified
Journal Article
Open access
PDF file
KBKarolien Buyl
Karolien Buyl
Makram MerimiMakram Merimi
Makram Merimi
RRRobim M Rodrigues
Robim M Rodrigues
SRSaida Rahmani
Saida Rahmani
MFMohammad Fayyad-Kazan
Mohammad Fayyad-Kazan
MNMehdi Najar
Mehdi Najar
Background: AT-MSCs display great immunoregulatory features, making them potential candidates for cell-based therapy. This study aimed to evaluate the “RBC lysis buffer” isolation protocol and immunological profiling of the so-obtained AT-MSCs. Methods: We established an immune-comparative screening of AT-MSCs throughout in vitro cell expansion (PM, P1, P2, P3, P4) and inflammatory priming regarding the expression of 28 cell-surface markers, 6 cytokines/chemokines, and 10 TLR patterns. Findings: AT-MSCs were highly expandable and sensitive to microenvironment challenges, hereby showing plasticity in distinct expression profiles. Both cell expansion and inflammation differentially modulated the expression profile of CD34, HLA-DR, CD40, CD62L, CD200 and CD155, CD252, CD54, CD58, CD106, CD274 and CD112. Inflammation resulted in a significant increase in the expression of the cytokines IL-6, IL-8, IL-1β, IL-1Ra, CCL5, and TNFα. Depending on the culture conditions, the expression of the TLR pattern was distinctively altered with TLR1–4, TLR7, and TLR10 being increased, whereas TLR6 was downregulated. Protein network and functional enrichment analysis showed that several trophic and immune responses are likely linked to these immunological changes. Conclusions: AT-MSCs may sense and actively respond to tissue challenges by modulating distinct and specific pathways to create an appropriate immuno-reparative environment. These mechanisms need to be further characterized to identify and assess a molecular target that can enhance or impede the therapeutic ability of AT-MSCs, which therefore will help improve the quality, safety, and efficacy of the therapeutic strategy.

20 June 2022 in Cells
Verified
Journal Article
Open access
PDF file
Makram MerimiMakram Merimi
Makram Merimi
SRSaida Rahmani
Saida Rahmani
ATAhmed Afailal Tribak
Ahmed Afailal Tribak
BFbouhtit fatima
bouhtit fatima
Hassan FahmiHassan Fahmi
Hassan Fahmi
MNMehdi Najar
Mehdi Najar
We are pleased to present this Special Issue of Cells, entitled ‘Feature Papers in Stem Cells’